latest news releases from the newsroom
Whitney Holding Corporation
Whitney Holding Corporation to Ring NASDAQ Opening Bell
NEW ORLEANS, Oct. 24, 2008 (GLOBE NEWSWIRE) -- Whitney Holding Corporation (Nasdaq:WTNY) Chairman and Chief Executive Officer John C. Hope, III will ring the NASDAQ Opening Bell on Monday, October 27th to celebrate Whitney's 125th anniversary.
Infinity Pharmaceuticals, Inc.
Infinity Initiates International Phase 3 Registration Trial of IPI-504 in Patients With Refractory GIST
CAMBRIDGE, Mass., Oct. 24, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced initiation of a Phase 3 registration trial of IPI-504 (retaspimycin hydrochloride), its lead inhibitor of heat shock protein 90 (Hsp90), in patients with refractory gastrointestinal stromal tumors (GIST). Initiation of the Phase 3 trial of IPI-504 follows promising safety and activity data reported earlier this year from a Phase 1 study in patients with refractory GIST and other soft tissue sarcomas. The trial is expected to be completed within approximately two years, positioning IPI-504 as the potential first-in-class Hsp90 inhibitor.